Literature DB >> 22346536

Influenza vaccine match with circulating strains and indicators of influenza strain impact - Canada 1980 to 1992.

E Ellis1, J M Weber, W Cuff, S G Mackenzie.   

Abstract

OBJECTIVES: To determine the similarity between influenza vaccine antigens and viruses associated with laboratory-confirmed infections by virus type/subtype, strain and influenza season; to correlate pneumonia and influenza hospitalization and mortality rates with the number of laboratory-confirmed influenza infections in an influenza season; and to develop predictive indicators of the likely incidence of current strains in the following season.
DESIGN: Ecological study using national laboratory, pneumonia and influenza hospitalization and mortality data.
SETTING: Canada, influenza seasons from 1980 to 1992. POPULATION STUDIED: Individuals with laboratory-confirmed influenza infections, pneumonia and influenza hospitalizations or deaths. INTERVENTION: Influenza immunization. MAIN
RESULTS: Similarity of circulating strains and vaccine antigens was 99% for A(H1N1), 65% for A(H3N2) and 65% for B strains. During outbreaks, pneumonia and influenza hospitalization, and mortality rates increased 19% or less and 21% or less for A(H1N1), respectively; 28% or less and 51% or less for A(H3N2), and 19% or less and 16% or less for B strains. There were usually fewer than 25 laboratory-confirmed A(H1N1) infections with a particular strain in a season if there had been more than 25 infections with similar strains the previous season. For A(H3N2), the figure was 100, and for B it was 150.
CONCLUSIONS: Matches were excellent for A(H1N1) and good for A(H3N2) plus B strains. Hospitalization and mortality rates increased substantially during outbreaks, eg, estimated 1609 excess deaths during a widespread A(H3N2) outbreak. This study identifies relationships that provide some ability to predict the incidence of a particular influenza strain in a coming season based on the incidence of strains similar to it in the previous season.

Entities:  

Keywords:  Influenza incidence; Influenza vaccine; Influenza-related hospitalizations and mortality

Year:  1998        PMID: 22346536      PMCID: PMC3250906          DOI: 10.1155/1998/374524

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  15 in total

1.  Influenza in Canada, 1989-1990 season.

Authors:  S G Mackenzie
Journal:  Can Dis Wkly Rep       Date:  1990-09-08

2.  Distribution of influenza vaccine in Canada.

Authors:  S G Mackenzie
Journal:  Can Dis Wkly Rep       Date:  1991-06-22

3.  Influenza in Canada, 1990-91 and 1991-92 season.

Authors: 
Journal:  Can Commun Dis Rep       Date:  1992-09-25

4.  Influenza activity in Canada, 1988-1989.

Authors:  M J Todd; E Ellis; A Carter; W Cuff; J Weber
Journal:  Can Dis Wkly Rep       Date:  1989-08-26

5.  A summary of influenza activity in Canada, 1987-1988 season.

Authors:  E Bollegraaf
Journal:  Can Dis Wkly Rep       Date:  1988-09-24

6.  Influenza in Canada, 1992-1993 season.

Authors: 
Journal:  Can Commun Dis Rep       Date:  1993-09-30

7.  Impact of epidemic type A influenza in a defined adult population.

Authors:  W H Barker; J P Mullooly
Journal:  Am J Epidemiol       Date:  1980-12       Impact factor: 4.897

8.  Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981.

Authors:  W P Glezen; M Decker; D M Perrotta
Journal:  Am Rev Respir Dis       Date:  1987-09

9.  Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B.

Authors:  N Sugaya; K Nerome; M Ishida; M Matsumoto; K Mitamura; M Nirasawa
Journal:  JAMA       Date:  1994-10-12       Impact factor: 56.272

10.  Pneumonia and influenza deaths during epidemics: implications for prevention.

Authors:  W H Barker; J P Mullooly
Journal:  Arch Intern Med       Date:  1982-01
View more
  1 in total

1.  Influenza pandemic planning and the paediatrician.

Authors:  E L Ford-Jones; R Williams; T Tam; B Yaffe; M Naus; S Tamblyn
Journal:  Paediatr Child Health       Date:  2000-09       Impact factor: 2.253

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.